blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3013844

EP3013844 - PROCESS FOR PREPARATION OF ABIRATERONE ACETATE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  08.02.2019
Database last updated on 24.04.2024
FormerExamination is in progress
Status updated on  11.05.2018
Most recent event   Tooltip08.02.2019Application deemed to be withdrawnpublished on 13.03.2019  [2019/11]
Applicant(s)For all designated states
Sun Pharmaceutical Industries LTD
17/B Mahal Industrial Estate Mahakali Caves Road
Andheri (East) Mumbai 400 093 / IN
[2016/18]
Inventor(s)01 / THENNATI, Rajamannar
Sun Pharmaceutical Industries Limited
Nima Compound
Near Pratham Enclave
Tandalja Road
Baroda 390020 / IN
02 / REHANI, Rajeev Budhdev
Sun Pharmaceutical Industries Limited
Nima Compound
Near Pratham Enclave
Tandalja Road
Baroda 390020 / IN
03 / PATEL, Nischalkumar Vinodbhai
Sun Pharmaceutical Industries Limited
Nima Compound
Near Pratham Enclave
Tandalja Road
Baroda 390020 / IN
04 / KANSARA, Riteshkumar Rajnikant
Sun Pharmaceutical Industries Limited
Nima Compound
Near Pratham Enclave
Tandalja Road
Baroda 390020 / IN
 [2016/18]
Representative(s)Harrison IP Limited
3 Ebor House
Millfield Lane
Nether Poppleton
York YO26 6QY / GB
[N/P]
Former [2016/18]O'Neill, Michelle
Harrison IP
1st Floor, Box Tree House
Northminster Business Park
Northfield Lane
York, YO26 6QU / GB
Application number, filing date14816900.624.06.2014
[2016/18]
WO2014IN00420
Priority number, dateIN2013MUM213324.06.2013         Original published format: IN 2133MU2013
[2017/16]
Former [2016/18]INMM2133201324.06.2013
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014207762
Date:31.12.2014
Language:EN
[2014/53]
Type: A1 Application with search report 
No.:EP3013844
Date:04.05.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 31.12.2014 takes the place of the publication of the European patent application.
[2016/18]
Search report(s)International search report - published on:AT31.12.2014
(Supplementary) European search report - dispatched on:EP26.01.2017
ClassificationIPC:C07J31/00, C07J43/00, C07J1/00
[2017/09]
CPC:
C07J43/003 (EP,US); C07J1/0003 (US); C07J1/0011 (EP,US);
C07J31/006 (EP,US)
Former IPC [2016/18]C07J13/00, C07J43/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/18]
TitleGerman:VERFAHREN ZUR HERSTELLUNG VON ABIRATERONACETAT[2016/18]
English:PROCESS FOR PREPARATION OF ABIRATERONE ACETATE[2016/18]
French:PROCÉDÉ DE PRÉPARATION D'ACÉTATE D'ABIRATÉRONE[2016/18]
Entry into regional phase19.01.2016National basic fee paid 
19.01.2016Search fee paid 
19.01.2016Designation fee(s) paid 
19.01.2016Examination fee paid 
Examination procedure19.01.2016Examination requested  [2016/18]
09.08.2017Amendment by applicant (claims and/or description)
15.05.2018Despatch of a communication from the examining division (Time limit: M04)
26.09.2018Application deemed to be withdrawn, date of legal effect  [2019/11]
25.10.2018Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2019/11]
Fees paidRenewal fee
27.06.2016Renewal fee patent year 03
27.06.2017Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
30.06.201805   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XPY]WO2014071984  (SYNTHON BV [NL]) [XP] 10 * claims 1, 4-6 * * page 9, paragraph 4 * [Y] 1-9;
 [E]WO2015015246  (IND CHIMICA SRL [IT]) [E] 1,10 * page 6, paragraph 6; example 1 *;
 [E]WO2015014686  (IND CHIMICA SRL [IT]) [E] 1,10* examples 3,4 *;
 [XY]  - POTTER G A ET AL, "Novel steroidal inhibitors of human cytochrome P450-17alpha (17-alpha-hydroxylase-C-17,20-lyase): Potential agents for the treatment of prostatic cancer", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, (19950101), vol. 38, no. 13, doi:10.1021/JM00013A022, ISSN 0022-2623, pages 2463 - 2471, XP002302489 [X] 10 * page 2467, column 1, paragraph 4 - column 2, paragraph 1 * [Y] 1-9

DOI:   http://dx.doi.org/10.1021/jm00013a022
International search[X]WO9320097  (BRITISH TECH GROUP [GB], et al);
 [A]WO2006021777  (BTG INT LTD [GB], et al);
 [XP]WO2014071983  (SYNTHON BV [NL])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.